19 études cliniques dans le Psoriasis

ERASURE

Secukinumab vs. placebo
(n = 738)

FIXTURE

Secukinumab vs. Etanercept et placebo
(n = 1 308)

SCULPTURE

(n = 967)

FEATURE

Secukinumab vs. placebo
(n = 177)

JUNCTURE

Secukinumab vs. placebo
(n = 182)

ALLURE

Secukinumab vs. placebo
(n = 214)

PROSE

(n = 1 660)

GESTURE

Secukinumab vs. placebo
(n = 205)

TRANSFIGURE

Secukinumab vs. placebo
(n = 198)

CLEAR

Secukinumab vs. Ustekinumab
(n = 676)

2PRECISE

Secukinumab vs. placebo
(n = 237)

CARIMA

Secukinumab vs. placebo
(n = 151)

OPTIMISE

(n = 16 487)

IPSI-PSO

(n = 120)

PSORITUS

Secukinumab vs. placebo
(n = 132)

GAIN

Optimisation de dose
(n = 772)

PRIME

Secukinumab vs. Fumaderm
(n = 202)

SCALP

Secukinumab vs. placebo
(n = 102)

AJP01

(n = 34)

5 études cliniques dans le Rhumatisme Psoriasique

FUTURE 1

Secukinumab vs. placebo
(n = 606)

FUTURE 2

Secukinumab vs. placebo
(n = 397)

FUTURE 3

Secukinumab vs. placebo
(n = 414)

FUTURE 4

Secukinumab vs. placebo
(n = 341)

FUTURE 5

Secukinumab vs. placebo
(n = 997)

4 études cliniques dans la Spondyloarthrite Ankylosante

MEASURE 1

Secukinumab vs. placebo
(n = 371)

MEASURE 2

Secukinumab vs. placebo
(n = 219)

MEASURE 3

Secukinumab vs. placebo
(n = 226)

MEASURE 4

Secukinumab vs. placebo
(n = 350)